Expanded FDA Lab Oversight May Result In Relaxed Regs For Some Test Kits
This article was originally published in The Gray Sheet
Executive Summary
FDA is considering changing how it regulates in vitro diagnostic test kits, perhaps down-classifying some kits, as it prepares to assume oversight of laboratory-developed-test services